PMID: 3915091Jan 1, 1985

Disposition, metabolism and pharmacokinetics of antihyperlipidemic agents in laboratory animals and man

Pharmacology & Therapeutics
M N Cayen

Abstract

No abstract listed.

References

Feb 23, 1976·Biochimica Et Biophysica Acta·S G Miguel, S Abraham
Aug 1, 1975·Australian and New Zealand Journal of Medicine·S M PondG Sudlow
Feb 2, 1978·The New England Journal of Medicine·W J CohnP S Guzelian
Mar 1, 1979·Canadian Journal of Physiology and Pharmacology·R N Redinger, R B Passi
May 1, 1979·Atherosclerosis·M N CayenD Dvornik
Apr 1, 1977·Atherosclerosis·R PichardoJ Davignon
Jan 1, 1975·The Journal of Pharmacy and Pharmacology·A Berlin
Jul 15, 1975·Experientia·M T Subbiah, A Kuksis
Nov 1, 1978·Clinical Pharmacokinetics·R Gugler
Sep 13, 1979·The New England Journal of Medicine·P Samuel
Apr 1, 1979·British Journal of Clinical Pharmacology·E M Faed, E G McQueen
Jun 12, 1979·European Journal of Clinical Pharmacology·R GuglerJ Hartlapp
May 1, 1979·Clinical and Experimental Pharmacology & Physiology·E M Faed, E G McQueen
Aug 1, 1979·European Journal of Clinical Pharmacology·W KruseG Schlierf
Aug 1, 1979·European Journal of Clinical Pharmacology·U AbshagenH Stork
Sep 1, 1979·Journal of Pharmaceutical Sciences·J SassardJ Traeger
Nov 1, 1979·Journal of Clinical Pharmacology·K A DeSanteT J Vecchio
Jan 1, 1978·The Western Journal of Medicine·D K Oxley, C L Fischer
Apr 1, 1978·Clinical Biochemistry·W T RobinsonM Kraml
Mar 1, 1978·Clinical and Experimental Pharmacology & Physiology·E M Faed, E G McQueen
May 1, 1978·British Journal of Clinical Pharmacology·E JähnchenU Groth
Nov 1, 1976·The American Journal of the Medical Sciences·C A DujovneK Hassanein
Jun 1, 1977·Journal of Pharmaceutical Sciences·H Bechgaard, S Jespersen
Nov 1, 1977·Journal of Pharmaceutical Sciences·T Taylor, L F Chasseaud
Oct 1, 1977·Journal of Pharmacokinetics and Biopharmaceutics·T D BjornssonT F Blaschke
Sep 1, 1976·Journal of Pharmaceutical Sciences·W A PhillipsJ R Schultz
Jan 1, 1976·Clinical and Experimental Pharmacology & Physiology·L A Simons
Aug 1, 1976·Pharmacological Research Communications·L PuglisiR Paoletti
Jan 1, 1976·Annals of the New York Academy of Sciences·E N TerryW Redisch
Jul 1, 1975·Proceedings of the Society for Experimental Biology and Medicine·J P NolanC Bishop
Jun 1, 1975·The Journal of Clinical Investigation·R GuglerD L Azarnoff
Feb 1, 1975·Biochemical Medicine·A Karmen, H Haut
Apr 11, 1975·European Journal of Clinical Investigation·A Sedaghat, E H Ahrens
Feb 1, 1975·Gut·R J West, J K Lloyd
Feb 26, 1976·The New England Journal of Medicine·R S ShulmanD S Fredrickson
Mar 1, 1986·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M N CayenD Dvornik
Sep 1, 1973·The Journal of Clinical Investigation·B M WolfeH P Brewster
Apr 1, 1974·The Journal of Clinical Investigation·A K Bhattacharyya, W E Connor
Sep 2, 1971·The New England Journal of Medicine·J K Weser, E Sellers
Dec 1, 1974·Journal of Pharmaceutical Sciences·H Ko, M E Royer
Jan 1, 1974·Pharmacology·E M Faed, E G McQueen
Feb 1, 1972·The American Journal of Digestive Diseases·J P Nolan, M V Ali
Nov 1, 1973·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M J Kendall, K Chan
Jul 1, 1974·Atherosclerosis·L Harthon, N Svedmyr
Apr 1, 1973·Proceedings of the Society for Experimental Biology and Medicine·A Coronato, G B Glass
Jun 1, 1973·European Journal of Clinical Pharmacology·C Harvengt, J P Desager
Jan 1, 1974·Proceedings of the Society for Experimental Biology and Medicine·N J LewisD R Feller
May 1, 1974·Journal of Pharmaceutical Sciences·G Levy, A Yacobi
Jul 1, 1974·Journal of Clinical Pharmacology·L F ChasseaudV H Saggers
Jul 26, 1974·European Journal of Clinical Pharmacology·J P TillementG Vassent
Oct 1, 1967·The Journal of Cell Biology·D SvobodaD L Azarnoff
Mar 1, 1972·Lipids·M L BierenbaumR I Raichelson
Sep 1, 1972·Toxicology and Applied Pharmacology·R B BeckettR J Cenedella
Jul 6, 1971·Annals of the New York Academy of Sciences·H M SolomonW B Abrams
May 1, 1970·The Journal of Clinical Investigation·G SalenS M Grundy
Aug 1, 1969·Metabolism: Clinical and Experimental·R G GouldC B Taylor
Jun 9, 1969·JAMA : the Journal of the American Medical Association·R C NorthcuttE G Stant
Mar 1, 1966·Clinica Chimica Acta; International Journal of Clinical Chemistry·L A Carlson
Jul 7, 1967·Biochemical Pharmacology·H M Solomon, J J Schrogie
Apr 4, 1981·Lancet·W S Phillips, S L Lightman
Apr 1, 1984·Annals of Internal Medicine·C A DujovneM Garty
May 23, 1980·Biochimica Et Biophysica Acta·F Sadoogh-Abasian, D F Evered
Jul 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·D W BilheimerJ L Goldstein
Jan 1, 1984·Biopharmaceutics & Drug Disposition·M V Calvo, A Dominguez-Gil
Apr 1, 1984·European Journal of Drug Metabolism and Pharmacokinetics·R MalleinH Ksavrelof
Jan 1, 1980·Therapeutic Drug Monitoring·M Rowland
Dec 1, 1982·Atherosclerosis·M N CayenD Dvornik
Jan 1, 1983·European Journal of Clinical Pharmacology·J T CallaghanD B Hunninghake
Jan 1, 1980·Annual Review of Pharmacology and Toxicology·M M Reidenberg, D E Drayer
Apr 1, 1980·European Journal of Clinical Pharmacology·U AbshagenJ Marinow
Jan 1, 1981·Annual Review of Biochemistry·N E Tolbert
Jan 1, 1982·Annual Review of Medicine·R J Havel, J P Kane
Jan 8, 1982·Journal of Chromatography·M C Caturla, J Albaigés
Aug 1, 1982·Journal of Toxicology and Environmental Health·T RozmanH Greim
Dec 1, 1982·Atherosclerosis·M N CayenD Dvornik
Feb 1, 1981·Pharmacological Research Communications·F R MaffeiO Tofanetti
Feb 1, 1981·Pharmacological Research Communications·L SautebinR Paoletti
May 4, 1981·Life Sciences·C E HigniteD H Huffman
Jul 1, 1981·Biochemical Pharmacology·H HayashiT Suga
Jan 1, 1981·European Journal of Clinical Pharmacology·P Anderson, H E Norbeck
Jun 1, 1980·European Journal of Clinical Pharmacology·C Harvengt, J P Desager
Jun 1, 1980·Atherosclerosis·M HanefeldH Haller
Sep 1, 1980·Atherosclerosis·G Rosenhamer, L A Carlson
Oct 1, 1980·Journal of Clinical Pharmacology·J P DesagerC Harvengt
Dec 1, 1980·Biochemical Pharmacology·J R BaldwinD R Feller
Sep 1, 1963·Journal of Atherosclerosis Research·A S ROGEN, J CAMPBELLFERGUSON
Sep 1, 1963·Journal of Atherosclerosis Research·J M THORP
May 1, 1964·The American Journal of Medicine·I M WEINER, G H MUDGE
Jan 1, 1962·Analytical Biochemistry·O PELLETIER, J A CAMPBELL

Citations

Sep 2, 1998·European Journal of Drug Metabolism and Pharmacokinetics·M NobilisJ Vlcek
Feb 4, 1992·Biochemical Pharmacology·R M SánchezJ C Laguna
Aug 1, 1987·Baillière's Clinical Endocrinology and Metabolism·R Fears
May 19, 2001·The Journal of Steroid Biochemistry and Molecular Biology·T E Johnson, B J Ledwith
Jun 22, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Ines ReicheStefanie M Bode-Böger
Oct 1, 1991·British Journal of Clinical Pharmacology·P J NeuvonenO Sundholm
Oct 1, 1995·British Journal of Pharmacology·M VázquezJ C Laguna
Dec 27, 1996·Annals of the New York Academy of Sciences·G M Williams, C Perrone
Mar 8, 2016·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·Stephan BroxThorsten Reemtsma
Nov 17, 1993·Biochemical Pharmacology·R M SánchezJ C Laguna
Jul 3, 2013·The Journal of Steroid Biochemistry and Molecular Biology·S KimT R Zacharewski
May 23, 2012·Expert Opinion on Pharmacotherapy·Rahul YadavHandrean Soran
Dec 3, 2011·Expert Opinion on Drug Safety·Rahul YadavHandrean Soran
Nov 1, 1990·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·J M MakowskaG G Gibson
Aug 1, 1989·Journal of Clinical Pharmacology·H FriedmanB W LeDuc
Jun 13, 2009·International Journal of Food Sciences and Nutrition·Jennifer SchweikartChristiane Schön
May 16, 1997·The Journal of Biological Chemistry·C L Rokos, B J Ledwith

Related Concepts

Hypolipidemic Agents
Metabolic Biotransformation
Athromidin
Drug Interactions
Mixed Function Oxygenases
Intestinal Absorption
Kidney Diseases
Liver Dysfunction
Niacin Manganese (2+) Salt
Plasma Protein Binding Capacity

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Systemic Juvenile Idiopathic Arthritis

Systemic juvenile idiopathic arthritis is a rare rheumatic disease that affects children. Symptoms include joint pain, but also fevers and skin rashes. Here is the latest on this disease.

Chromatin Regulation and Circadian Clocks

The circadian clock plays an important role in regulating transcriptional dynamics through changes in chromatin folding and remodelling. Discover the latest research on Chromatin Regulation and Circadian Clocks here.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.

Myocardial Stunning

Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.

Pontocerebellar Hypoplasia

Pontocerebellar hypoplasias are a group of neurodegenerative autosomal recessive disorders with prenatal onset, atrophy or hypoplasia of the cerebellum, hypoplasia of the ventral pons, microcephaly, variable neocortical atrophy and severe mental and motor impairments. Here is the latest research on pontocerebellar hypoplasia.

Cell Atlas Along the Gut-Brain Axis

Profiling cells along the gut-brain axis at the single cell level will provide unique information for each cell type, a three-dimensional map of how cell types work together to form tissues, and insights into how changes in the map underlie health and disease of the GI system and its crosstalk with the brain. Disocver the latest research on single cell analysis of the gut-brain axis here.

Chronic Traumatic Encephalopathy

Chronic Traumatic Encephalopathy (CTE) is a progressive degenerative disease that occurs in individuals that suffer repetitive brain trauma. Discover the latest research on traumatic encephalopathy here.